Teiji Takechi

2.2k total citations
63 papers, 1.9k citations indexed

About

Teiji Takechi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Teiji Takechi has authored 63 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Teiji Takechi's work include Colorectal Cancer Treatments and Studies (44 papers), Gastric Cancer Management and Outcomes (18 papers) and Pancreatic and Hepatic Oncology Research (17 papers). Teiji Takechi is often cited by papers focused on Colorectal Cancer Treatments and Studies (44 papers), Gastric Cancer Management and Outcomes (18 papers) and Pancreatic and Hepatic Oncology Research (17 papers). Teiji Takechi collaborates with scholars based in Japan, United States and Ukraine. Teiji Takechi's co-authors include Masakazu Fukushima, Junji Uchida, Fumio Nakagawa, A Fujioka, Hiroyuki Okabe, Masahiko Watanabe, Takashi Kobunai, Setsuo Takeda, Mamoru Nukatsuka and Donna Voeller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Teiji Takechi

62 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Teiji Takechi Japan	26	1.3k	760	644	266	237	63	1.9k
Loredana Vecchione Italy	18	964 0.7×	542 0.7×	444 0.7×	213 0.8×	233 1.0×	33	1.5k
C J Allegra United States	17	1.2k 0.9×	610 0.8×	334 0.5×	247 0.9×	229 1.0×	30	1.5k
Davide Ciardiello Italy	22	1.4k 1.0×	803 1.1×	496 0.8×	223 0.8×	496 2.1×	86	2.2k
Matthew Squires United States	25	825 0.6×	1.1k 1.5×	414 0.6×	137 0.5×	238 1.0×	71	1.9k
Hendrik‐Tobias Arkenau United Kingdom	14	1.4k 1.1×	556 0.7×	423 0.7×	135 0.5×	189 0.8×	29	1.8k
H-J Lenz United States	13	908 0.7×	603 0.8×	253 0.4×	159 0.6×	228 1.0×	21	1.4k
Edward H. Lin United States	22	1.1k 0.9×	358 0.5×	333 0.5×	662 2.5×	217 0.9×	51	1.6k
Yoichi Ozawa Japan	14	899 0.7×	700 0.9×	352 0.5×	92 0.3×	290 1.2×	44	1.9k
Marta Schirripa Italy	23	1.4k 1.1×	489 0.6×	538 0.8×	202 0.8×	403 1.7×	125	1.9k
İbrahim Halil Şahin United States	20	1.2k 0.9×	427 0.6×	302 0.5×	267 1.0×	441 1.9×	97	1.7k

Countries citing papers authored by Teiji Takechi

Since Specialization

Citations

This map shows the geographic impact of Teiji Takechi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teiji Takechi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teiji Takechi more than expected).

Fields of papers citing papers by Teiji Takechi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teiji Takechi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teiji Takechi. The network helps show where Teiji Takechi may publish in the future.

Co-authorship network of co-authors of Teiji Takechi

This figure shows the co-authorship network connecting the top 25 collaborators of Teiji Takechi. A scholar is included among the top collaborators of Teiji Takechi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teiji Takechi. Teiji Takechi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsunekuni, Kenta, Masamitsu Konno, Naotsugu Haraguchi, et al.. (2019). CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure. Scientific Reports. 9(1). 14861–14861. 53 indexed citations

Kobunai, Takashi, Kazuaki Matsuoka, & Teiji Takechi. (2019). ChIP-seq Analysis to Explore DNA Replication Profile in Trifluridine-treated Human Colorectal Cancer Cells In Vitro. Anticancer Research. 39(7). 3565–3570. 4 indexed citations

Nukatsuka, Mamoru, Hitoshi Saitô, Shinzaburo Noguchi, & Teiji Takechi. (2019). Estrogen Down-regulator Fulvestrant Potentiates Antitumor Activity of Fluoropyrimidine in Estrogen-responsive MCF-7 Human Breast Cancer Cells. In Vivo. 33(5). 1439–1445. 6 indexed citations

Ishida, Kaoru, Kohei Kume, Kei Sato, et al.. (2017). Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil. Scientific Reports. 7(1). 2262–2262. 8 indexed citations

Matsuoka, Kazuaki, Takashi Kobunai, Mamoru Nukatsuka, & Teiji Takechi. (2017). Improved chemoradiation treatment using trifluridine in human colorectal cancer cells in vitro. Biochemical and Biophysical Research Communications. 494(1-2). 249–255. 8 indexed citations

Suzuki, Norihiko, Fumio Nakagawa, Kazuaki Matsuoka, & Teiji Takechi. (2016). Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts. Oncology Reports. 36(6). 3123–3130. 11 indexed citations

Shimamoto, Yuji, Mamoru Nukatsuka, Teiji Takechi, & Masakazu Fukushima. (2015). Association between mRNA expression of chemotherapy-related genes and clinicopathological features in colorectal cancer: A large-scale population analysis. International Journal of Molecular Medicine. 37(2). 319–328. 13 indexed citations

Nakamura, Ayako, Go Nakajima, Ryuji Okuyama, et al.. (2013). Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase. Gastric Cancer. 17(1). 188–195. 32 indexed citations

Kawakami, Kazuyuki, Sayaka Tsukioka, Makoto Oda, et al.. (2009). Different histological types of non‐small cell lung cancer have distinct folate and DNA methylation levels. Cancer Science. 100(12). 2325–2330. 39 indexed citations

10.

Ooyama, Akio, Yoshihiro Okayama, Teiji Takechi, et al.. (2007). Genome‐wide screening of loci associated with drug resistance to 5‐fluorouracil‐based drugs. Cancer Science. 98(4). 577–583. 24 indexed citations

11.

Kobunai, Takashi, Akio Ooyama, Shin Sasaki, et al.. (2007). Changes to the dihydropyrimidine dehydrogenase gene copy number influence the susceptibility of cancers to 5-FU-based drugs: Data mining of the NCI-DTP data sets and validation with human tumour xenografts. European Journal of Cancer. 43(4). 791–798. 10 indexed citations

12.

Ooyama, Akio, Teiji Takechi, Etsuko Toda, et al.. (2006). Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5‐fluorouracil‐based drugs. Cancer Science. 97(6). 510–522. 16 indexed citations

13.

Kubota, Tetsuro, Masahiko Watanabe, Norihito Wada, et al.. (2003). Gene expression in colorectal cancer and in vitro chemosensitivity to 5‐fluorouracil: A study of 88 surgical specimens. Cancer Science. 94(7). 633–638. 44 indexed citations

14.

Terashima, Masanori, Takashi Irinoda, Akinori Takagane, et al.. (2003). Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity. European Journal of Cancer. 39(16). 2387–2394. 27 indexed citations

15.

Fukushima, Masakazu, Hiroyuki Okabe, Teiji Takechi, Wataru Ichikawa, & Renzo Hirayama. (2002). Induction of thymidine phosphorylase by interferon and taxanes occurs only in human cancer cells with low thymidine phosphorylase activity. Cancer Letters. 187(1-2). 103–110. 21 indexed citations

16.

Takechi, Teiji, A Fujioka, Eiji Matsushima, & Masakazu Fukushima. (2002). Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells. European Journal of Cancer. 38(9). 1271–1277. 78 indexed citations

17.

Takechi, Teiji, et al.. (2001). Screening of Differentially Expressed Genes in 5‐Fluorouracil‐resistant Human Gastrointestinal Tumor Cells. Japanese Journal of Cancer Research. 92(6). 696–703. 25 indexed citations

18.

Miyamoto, Shin’ichi, Atsushi Ochiai, Narikazu Boku, et al.. (2001). Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa. International Journal of Oncology. 18(4). 705–13. 38 indexed citations

19.

Takechi, Teiji, Hiroyuki Okabe, Akio Fujioka, Yuko Murakami, & Masakazu Fukushima. (1998). Relationship between Protein Levels and Gene Expression of Dihydropyrimidine Dehydrogenase in Human Tumor Cells during Growth in Culture and in Nude Mice. Japanese Journal of Cancer Research. 89(11). 1144–1153. 41 indexed citations

20.

Chu, Edward, Donna Voeller, Kristen L. Jones, et al.. (1994). Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells. Molecular and Cellular Biology. 14(1). 207–213. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact